Samoncho Clinic

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials

Phase

• Phase 35 trials

Status

• Active, not recruiting3 trials
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company5 trials

Running trials

• Recruiting

  A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  NCT07602582· Phase 3· Eli Lilly and Company· Source

  Contact: Takahiro Yokoyama (principal investigator)

• Recruiting

  A Study of Brenipatide in Participants With Alcohol Use Disorder

  NCT07219953· Phase 3· Eli Lilly and Company· Source

  Contact: Takahiro Yokoyama (principal investigator)

• Recruiting

  A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

  NCT07219966· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting